Literature DB >> 2864716

The neuroleptic malignant syndrome--a review.

W R Gibb, A J Lees.   

Abstract

The neuroleptic malignant syndrome (NMS) is an uncommon disorder characterised by muscular stiffness and hyperthermia. It is caused by the administration of neuroleptics or by the acute withdrawal of levodopa therapy in idiopathic Parkinson's disease. An identical syndrome may be seen rarely in untreated catatonic schizophrenia. Shock, respiratory failure and myoglobinuria occur sometimes with serious consequences. Treatment should include active cooling measures and the administration of dopamine agonists. Dantrolene may also be of benefit in severe cases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2864716

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  8 in total

1.  Neuroleptic malignant syndrome: nine cases.

Authors:  A Freyne; A McCarthy
Journal:  Ir J Med Sci       Date:  1988-10       Impact factor: 1.568

2.  Neuroleptic malignant syndrome: a review.

Authors:  R A O'Brien; G B Young
Journal:  Can Fam Physician       Date:  1989-05       Impact factor: 3.275

3.  Neuroleptic malignant syndrome: another medical cause of acute abdomen.

Authors:  T C Lo; M R Unwin; I W Dymock
Journal:  Postgrad Med J       Date:  1989-09       Impact factor: 2.401

4.  Neuroleptic malignant syndrome: a case for electroconvulsive therapy.

Authors:  C C Harland; M M O'Leary; R Winters; J Owens; B Hayes; V Melikian
Journal:  Postgrad Med J       Date:  1990-01       Impact factor: 2.401

5.  Neuroleptic Malignant Syndrome: Complications, Outcomes, and Mortality.

Authors:  Sumul Modi; Devanshi Dharaiya; Lonni Schultz; Panayiotis Varelas
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

6.  The muscle findings in the neuroleptic malignant syndrome associated with lysergic acid diethylamide.

Authors:  W M Behan; A M Bakheit; P O Behan; I A More
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

7.  Postoperative neuroleptic malignant syndrome. A case report.

Authors:  P Patel; G Bristow
Journal:  Can J Anaesth       Date:  1987-09       Impact factor: 5.063

Review 8.  Aetiology and treatment of neuroleptic malignant syndrome.

Authors:  C Harpe; A Stoudemire
Journal:  Med Toxicol       Date:  1987 May-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.